• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV 1.43% 34.5¢

CLEO DIAGNOSTICS LTD

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. It has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
COV 16/01/25 11 3.8K
16/01/25 Last post  CognacHennessy Comments Created with Sketch.  11  Views Created with Sketch.  3.8K 
COV 10/12/24 6 2.4K
10/12/24 Last post  Whampoa Comments Created with Sketch.  6  Views Created with Sketch.  2.4K 
COV 27/11/24 0 263
27/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  263 
COV 15/11/24 9 4.2K
15/11/24 Last post  chelseadude65 Comments Created with Sketch.  9  Views Created with Sketch.  4.2K 
COV 04/10/24 0 574
04/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  574 
COV 04/10/24 0 266
04/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
COV 23/09/24 0 306
23/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  306 
COV 06/09/24 6 4.1K
06/09/24 Last post  ballbreaker Comments Created with Sketch.  6  Views Created with Sketch.  4.1K 

See All Discussions arrow Created with Sketch.

Timeline

CLEO Further Expands Ovarian Cancer Trial with Siles Health
10 Dec 09:03
 
Results of Annual General Meeting
27 Nov 11:50
 
The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial
27 Nov 08:31
 
Quarterly activities and cashflow report
16 Oct 16:27
 
Letter to Shareholders
04 Oct 10:29
 
Notice of Annual General Meeting/Proxy Form
04 Oct 10:26
 
View More arrow Created with Sketch.
(20min delay)
Last
34.5¢
Change
-0.005(1.43%)
Mkt cap ! $28.15M
Open High Low Value Volume
35.0¢ 36.0¢ 34.5¢ $11.66K 33.00K

Buyers (Bids)

No. Vol. Price($)
2 11691 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 55177 2
View Market Depth
Last trade - 15.58pm 17/01/2025 (20 minute delay) ?
COV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.